157 results about "Infection control" patented technology

The present invention is a system and method for disease mapping and infection control. It may collect data from many sources, including through the tracking of Entities and external sources. Such data may be analysed by the system and represented visually. The system further facilitates data modelling. The present invention facilitates calculations of risk and exposure to an infection posed to a person, location or community. The system may be used to test and monitor infection spread and control measures. It can further be configured so as to produce reporting based upon its data to produce information relevant to the creation of infection control policies. The reports may also be utilized to develop standards and measures to improve the operation response to an outbreak of infection within an Institution or a Geographical Area, at the syndromic or pandemic levels.

A system identifies multiple medical conditions, observations, and laboratory test results using active sensors and predetermined rules to identify infected patients. An infection control and workflow management system includes a repository of worker information identifying healthcare workers for performing infection control tasks as well as worker associated communication data for use in informing healthcare workers of infection control tasks to be performed. A detection processor automatically detects infection in patients from multiple different sources including from at least one of, (a) a medical record evaluated upon admission of a patient to a hospital and (b) a laboratory test result. A workflow processor uses the worker information for automatically communicating a message to inform a healthcare worker of a task to be performed to initiate infection control tasks using communication data in response to detection of an infected patient.

Embodiments of the invention provide virtual reality tools used to develop improved infection control solutions. The virtual reality tools may be applied to a variety of health care environments to develop improved infection control solutions, including improved training systems for modifying human behavior regarding hand washing (or other infection control behaviors), improved systems for evaluating the effectiveness of a proposed infection control solution, and for a producer / seller of anti-microbial products to demonstrate the superiority of one product over another or the superiority of one proposed solution over another.

The present invention is a centralized system for the automated monitoring and reporting of compliance to infection prevention policies. It is focused on the proactive reduction (elimination) of pathogenic organisms causing infection within the facility by enforcing best practices for infection prevention.

The present invention discloses a management system for an entire process of hospital infection prevention and control, and a method thereof. The system comprises a data collection / monitoring indicator module, and an interface module with a third-party system. The data collection / monitoring indicator module is connected with a daily monitoring and displaying subsystem, a data analysis / statistics module, and an auxiliary alarm setting and displaying subsystem; the daily monitoring and displaying subsystem is connected with the data analysis / statistics module; the auxiliary alarm setting and displaying subsystem is connected with a hospital infections reporting and feedback subsystem; the hospital infections reporting and feedback subsystem is connected with the data analysis / statistics module. The interface module with the third-party system is used for interfacing the various systems. The beneficial effects of the system and method disclosed by the present invention are that comprehensive, fast and accurate retrieval is carried out through the set hospital infection alarm determination condition information, a case range required to be consulted by the infection control staff is reduced, and infection control efficiency is improved.

The current invention provides this advance in infection control via its unique application of active sterilization to a catheter or implant. While most catheters, and many implants, are passive devices, the current invention will provide an active component as a integral part of the implanted catheter or device to continuously or intermittently sterilize the exposed surfaces / areas of the device. This active sterilization may be accomplished by a variety of mechanisms, including, application of heat, RF, microwave, ultrasound, ultraviolet radiation or other energy capable of sterilizing the device or dislodging any problematic Biofilm that may form. The active sterilization may also employ the pumping of a sterilizing chemical from an attached drug reservoir, the use of electricity or freezing temperatures or any other mechanism for either inhibiting, killing or dislodging any infectious material in contact with the implant. One major advantage of this design is that through the use of a small, battery powered or inductively powered sterilization element, the implanted catheter or device can be effectively sterilized without requiring the standard removal surgery, waiting period, then replacement of the infected device. This is expected to translate into greatly improved outcomes (particularly for devices where infection may be catastrophic, ie a prosthetic knee or hip), greatly improved costs, and greatly improved longevity of susceptible devices (ie IV ports, etc.).

The present invention is a system and method for performing real-time infection control over a computer network. The method comprises obtaining a sample of a microorganism at a health care facility, sequencing a first region of a nucleic acid from the microorganism sample, comparing the first sequenced region with historical sequence data stored in a database, determining a measure of phylogenetic relatedness between the microorganism sample and historical samples stored in the database, and providing infection control information based on the phylogenetic relatedness determination to the health care facility, thereby allowing the health care facility to use the infection control information to control or prevent the spread of an infection.

The invention discloses an easy-to-stick skin and soft tissue wound attracting and lavaging device which comprises a medical sponge block, build-in tubes and a sticking membrane. The sticking membrane enwraps the whole medical sponge block from the back. The lower surface of the sponge block is a region which is in contact with the wound. The sticking membrane forms a circle of an enclosed blending surface on the periphery of the lower surface to be blended with skin. The build-in tubes which are provided with a plurality of lateral holes are inserted in the sponge block, eduction ends of which are provided with atomseal ports at sticking membrane piercing out parts for maintaining the subpressure in the sponge during the attracting process. The product can carry out the vacuum sealing drainage on the wound and the enclosed lavage on infective wounds, has the advantages of lightness and using convenience and can relieve trivial works of repeated wound cleaning and change dressing of medical staff by one-time operation and achieve cleaning and draining effects better than repeated dressing changes, thereby promoting the infection control on the infective wounds and the rapid growth of granulation tissues.

A infection control station includes: a mounting unit; a cover rotatably attached to the mounting unit, adapted to transition between an open position and a closed position; a pump adapted to dispense the hand sanitizer; a site window to view the hand sanitizer when the cover is in the closed position; an aperture adapted to dispense the towel; and a site window to view the towel when the cover is in the closed position. The station may also include a hinge that pivotally attaches a first side of the cover to the mounting unit; a lock that releasably secures a second side of the cover against the mounting unit; and a shelf that is accessible when the cover is in the open position and is not accessible when the cover is in the closed position.

Air decontamination method and device designed for bioterrorism, nerve gas, toxic mold, small pox, Ebola, anthrax and other agents require built in air sampling, rapid filter changes and the ability to use a mobile, transportable and connectable system in positive mode to push contaminates away or in negative mode to contain a toxin from spreading. This application combines features in respirators, industrial and hospital grade air filtration with the ability to provide air testing to guide the connection of the device with other treatment modules or existing HVAC and other equipment. With this new flexibility, ozone, UV, absorption, Thermal destruction, filters and liquid chemical neutralization can be manually or automatically adapted for emergency response to both daily airborne contamination and military grade terrorist threats of airborne contamination. The air decontamination units may be used to decontaminate the air after industrial and medical contaminations and terrorist biological, chemical and radiological attacks, for example. Mobile isolation units, and methods of decontaminating rooms, are disclosed, as well as Well as infection control and emergency response usage as an emergency clean air supply when connected to escape hoods, decon tents, or containment barriers to protect structures from homes to business from outside toxic agents. The unit can be powered by normal AC, 120 volts or 240 or be adapted to battery or field power supply units.

A transdermal intraosseous device includes a transdermal adapter for an external prosthetic device for a bone of a patient and a bone fixator including a distal portion coupled to the transdermal adapter and a proximal portion for anchoring into the bone. The transdermal adapter includes a dome-shaped portion for transcutaneous implantation and an external shaft extending from the dome-shaped portion. A dermal transition structure is configured to include a controlled roughness gradient from the external shaft to the dome-shaped portion and configured for use in infection control at a dermis layer of the patient.

The invention relates to a wound-protecting liquid, which is suitable for controlling the infection of wounds on the human body surface and promoting wound healing, and also relates to a preparation method of the wound-protecting liquid, which belongs to the technical field of medicine for medical surgery. Each 1000g weight of the finished solution formed by it contains: silver ion powder 0.16-0.36g, gelatin 0.10-0.40g, dibasic acid 0.50-1.00g, penetrant 12-14.3g, tartaric acid 0.40-0.80g, The rest is pure water. One of the advantages is that the stabilizer with penetration effect is used in the formula, which can penetrate into the deep tissue of the wound, kill the bacteria and endotoxin in the deep part, and loosen and dissolve the necrotic tissue, pus and blood clots out of the body, which helps It can shorten the wound healing time; second, it will not form obvious drug film and drug resistance after long-term use, and can effectively shorten the treatment cycle; third, it has no side effects on patients and the product has no peculiar smell and no allergies; fourth , the method has few process steps, and the conditions are not harsh, and can adapt to the requirements of mass production.

Thermally-conductive laboratory bath media can be used to replace conventional wet media or dry solid blocks in existing thermal baths for heating or cooling samples with advantageous maintenance and microbial control benefits. The media is typically in the form of metallic or metallic-coated pellets that have rounded edges, hardened surface, a smooth polished finish, and are sized small for efficient thermal communication between pellets and samples. Laboratory bath improvements are disclosed with various advanced controls and adaptations for thermal control as well as infection control.